NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Liabilities and Shareholders Equity (2010 - 2026)

Updated

NovelStem International (NSTM) posted Liabilities and Shareholders Equity of $64,687 for Q2 2026, up 323.0% from $15,292 a year earlier but down 35.9% from the prior quarter.

Analysis

NovelStem International (NSTM) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, NovelStem International's Liabilities and Shareholders Equity came in at $15,786, down 90.1% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for four consecutive years, with a four-year compound annual growth rate of -72.1% (FY2021 to FY2025).
  • In prior years, NovelStem International's Liabilities and Shareholders Equity was $160,111 in FY2024 (-92.9%), $2.25 million in FY2023 (-1.4%), $2.29 million in FY2022 (-12.4%) and $2.61 million in FY2021.
  • Quarterly Liabilities and Shareholders Equity has run from a low of $14,849 in Q3 2025 to a high of $2.61 million in Q4 2021 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in 1 of the last seven quarters, with an average decline of 23.4%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q2 2026, with growth of 323.0%; the weakest was Q1 2025, with a decline of 93.8%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $100,912 (Q1 2026), $15,786 (Q4 2025) and $14,849 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 201.06 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 135.12 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 115.83 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 49.36 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 201.13 Bn
10 NovelStem International 493,324.54 346,279.54 - 64,687.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64,687.00
Mar 31, 2026 100,912.00
Dec 31, 2025 15,786.00
Sep 30, 2025 14,849.00
Jun 30, 2025 15,292.00
Mar 31, 2025 149,987.00
Dec 31, 2024 160,111.00
Sep 30, 2024 198,482.00
Jun 30, 2024 102,000.00
Mar 31, 2024 2.40 Mn
Dec 31, 2023 2.25 Mn
Sep 30, 2023 2.02 Mn
Jun 30, 2023 2.10 Mn
Mar 31, 2023 2.20 Mn
Dec 31, 2022 2.29 Mn
Sep 30, 2022 2.23 Mn
Jun 30, 2022 2.35 Mn
Dec 31, 2021 2.61 Mn
Sep 30, 2013 33.71 Mn
Jun 30, 2013 25.60 Mn
API Access

NovelStem International Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NSTM&period=max&api_key=YOUR_API_KEY